Galapagos NV
GLPG
$28.92
Share price
0.05%
Change (1 day)
-22.78%
Change (1 year)
Categories
Galapagos NV (GLPG) - Total assets
Total assets on the balance sheet as of September 2023 : $4.70 B
According to Galapagos NV's latest financial reports the company's total assets are $4.70 B. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Galapagos NV - Total assets on balance sheet (from 2008 to 2023)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2022-12-31 | $5.07 B | -13.79% |
| 2021-12-31 | $5.88 B | -16.37% |
| 2020-12-31 | $7.03 B | 3.45% |
| 2019-12-31 | $6.79 B | 312.82% |
| 2018-12-31 | $1.64 B | 6.65% |
| 2017-12-31 | $1.54 B | 35.4% |
| 2016-12-31 | $1.14 B | 135.7% |
| 2015-12-31 | $0.48 B | 47.09% |
| 2014-12-31 | $0.32 B | -17.11% |
| 2013-12-31 | $0.39 B | 27.49% |
| 2012-12-31 | $0.31 B | 49.13% |
| 2011-12-31 | $0.20 B | -19.09% |
| 2010-12-31 | $0.25 B | 25.3% |
| 2009-12-31 | $0.20 B | 23.95% |
| 2008-12-31 | $0.16 B | -23.5% |
| 2007-12-31 | $0.21 B | -2.01% |
| 2006-12-31 | $0.22 B | 129.93% |
| 2005-12-31 | $96.38 M | 355.09% |
| 2004-12-31 | $21.17 M |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $167.55 B | 3,462.84% | 🇺🇸 USA |
 Abbott Laboratories ABT | $73.21 B | 1,456.77% | 🇺🇸 USA |
 AbbVie ABBV | $134.71 B | 2,764.40% | 🇺🇸 USA |
 Sanofi SNY | $139.81 B | 2,872.95% | 🇫🇷 France |
 Merck MRK | $106.67 B | 2,168.26% | 🇺🇸 USA |
 AstraZeneca AZN | $101.11 B | 2,050.12% | 🇬🇧 UK |
 GlaxoSmithKline GSK | $75.11 B | 1,497.16% | 🇬🇧 UK |
 Fortress Biotech
FBIO | $0.15 B | -96.80% | 🇺🇸 USA |
 Teva Pharmaceutical Industries TEVA | $43.47 B | 824.51% | 🇮🇱 Israel |